phase readout
saveNCT05399329: Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan
COMPLETEDupdated 1mo ago
community read0 votes
Sponsor: Pfizer. Phase: . Conditions: Breast Cancer
view source ↗
comments(0)
5-min edit window · permanent after that